Background: Nosocomial infection caused by antibiotic resistance bacteria is increasing in the world. Resistance to extendedspectrum beta-lactamase (ESBLs) is one of the most important antibiotic resistance mechanisms. Objectives: According to prevalence of E. coli producing ESBL, the aim of this study was to identify the blaCTX and blaSHV genes, which are the causing genes of the resistance to beta-lactam antibiotics by Multiplex-PCR method. Methods: A total of 100 isolates of E. coli were collected from the Milad Hospital in Tehran. Disk diffusion method was done and ESBL positive isolates were determined by combination disc test. DNA extraction of them was carried out and the presence of blaCTX and blaSHV genes was evaluated by using the M-PCR method. Results: By using the molecular method on all isolates, 46 of them were positive for the CTX gene, three isolates were positive for the SHV gene, and none of the isolates have both blaCTX and blaSHV genes. Antibiogram test was done on all samples in which 17 of them were resistant to antibiotics. Conclusions: Based on the goals of this study for investigation of frequency of SHV and CTX antibiotic resistance genes in collected isolates in order to improve PCR detection method, achieved results emphasized that the M-PCR method, with high accuracy and sensitivity, should be used as the substitution of phenotype tests in clinical laboratories. In addition, avoiding the indiscriminate prescribing of antibiotics is an important necessity.
Background
With the discovery of antibiotics (Fleming, 1928) , the emergence of new antibiotics and their spread use in the treatment of bacterial infectious diseases, bacterial resistance against the anti-bacterial materials happened (1) . One of the different strategies employed by the bacteria in order to be safe from the bad and destructive effects of antibiotics, which are being used in the gram negative bacteria against the beta-lactamase antibiotics, is the production of the beta-lactamase enzymes, which inactivate them through the hydrolysis of the central core in the betalactamase antibiotics (2, 3) . The continuity in the use of these groups of antibiotics leads into the emergence of ESBLs, and the first identification of worldwide detection of ESBL have been done in the early 1980s in Germany (4) (5) (6) . To date, approximately more than 200 different types of ESBLs have been discovered in the world as most of them have been seen in the family of Enterobacteriaceae (7) . Transmission of ESBL-producing organisms caused an increase in hospital-acquired infections worldwide (8) . One of the methods to classify Betalactamase, have been divided into four groups, A, B, C, and D based on the type of substrate, ability of prevention, and physical characteristics; regarding this classification, the widespread enzymes were located in group A and they include the derivatives of mutated enzymes such as TEM and SHV (9-11). Beta-lactamase of CTX-M types are widely distributed through the plasmids carrying ESBL, which are lacking TEM and SHV ; for the first time, they were reported in Europe in the late 1980s (12, 13) . Escherichia coli is one of the most common bacterial agents that has been isolated from human infections (14) . This bacterium is the original member of the Enterobacteriaceae family and it is the main factor of many hospital infections such as sepsis, neonatal meningitis, gastroenteritis, and especially urinary tract infections (15) .
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Objectives
Therefore, studying the antibiotic sensitivity patterns as well as the presence of beta-lactamase genes in the clinical samples of E. coli were considered as the aims of this research.
Methods

Sample Collection and Antibiotics Sensitivity and Resistance Pattern
In this research study, a total of 100 clinical isolates of E. coli related to urine isolates, scars, blood, respiratory secretions, and chips of patients in the microbiology clinical laboratory of Milad Hospital in Tehran, in 2015, were collected. All isolates, after the accurate identification and biochemical tests performed at -80°C, were kept. The sensitivity pattern and antibiotic resistance were defined by the disc diffusion method in accordance with the clinical and laboratory standards (CLSI, 2015) under the culture conditions of Mueller Hinton agar. The discs (Mast) were: Ampicillin, cephalexin, ofloxacin, nitrofurantoin, cefuroxime, nalidixic acid, imipenem, ceftriaxone, fluoxetine, ceftazidime, tobramycin, chloramphenicol, cefotaxime, tetracycline, gentamicin, norfloxacin, ciprofloxacin, cefazolin, cefixime, cotrimoxazole, amikacin, ceftizoxime, and meropenem.
After placing the antibiotic discs regarding the standard distance on the surface of the related environment, the plate was put in the incubator (37°C) for 18 to 24 hours. To identify the isolates producing ESBLs, the confirmation test was used. The testing discs, based on the combination discs, were ceftazidime and ceftazidime plus clavulanic acid, as well as cefotaxime and cefotaxime plus clavulanic acid under the conditions of Mueller Hinton Agar in a distance of 20 mm (from each other). Finally, after 24 hours of incubation at 37 degrees, E. coli producing ESBLs were determined through increasing the diameter size of halo (about 5 mm or more than it) around the ceftazidime disk/ clavulanic acid or cefotaxime clavulanic acid.
DNA Extraction from Bacteria
DNA of all samples was extracted by using the DNG-Plus kit (SinaClone, Iran).
Primers
Nucleotide sequence of the primers used for tracking blaSHV and blaCTX genes for PCR test is shown in Table 1 (16).
PCR Method Optimization
Optimization of Multiplex PCR test in order to detect the blaCTX and blaSHV genes in E. coli was done through the optimization of the concentration of components, which were used in the polymerase chain reaction process. Materials and the required M-PCR factors were: 10× PCR buffer 2.5 µL, forward primer (CTX) (0.2 µM ) 0.5 µL, reverse primer (CTX) (0.2 µM ) 0.5 µL, forward primer (SHV ) (0.2 µM ) 0.5 µL, reverse primer (SHV ) (0.2 µM ) 0.5 µL, Mgcl 2 (50 mm) 0.75 µL, dNTp mix (10 mm) (thermo scientific) 0.5 µL, Taq DNA polymerase (thermo scientific) 0.3 (1.5 unit) µL, DNA template or POS control 5 µL, D.D.W 14 µL, and total volume 25 µL. PCR was performed using an initial denaturation condition for five minutes at 94°C, 30 amplification cycles (denaturing 94°C for one minute, annealing at 60°C for one minute, and extension at 72°C for 1 minute) and a final elongation step for seven minutes at 72°C in the PCR machine (My Gene™ (Model MG 96G)).
Then, PCR product of each isolate was mixed with 2 µL of loading buffer (guide buffer) (IGF) and electrophoresis was done with the use of agarose gel (CinnaGen, Iran), 1.5%, along the size marker of Ladder mix (Thermo Scientific). At the end, it was determined that the PCR products of CTX gene and SHV gene were fragments of 593 bp and 747 bp, respectively.
Determination of Limit of Detection and Specificity of PCR Test
Determination of limit of detection of PCR test was done by the serial dilution method with the dilutions of 10 -1 to 10 -7 separately for SHV and CTX genes. In addition, the DNA of eight strains consists of different bacteria such as salmonella, Mycobacterium tuberculosis, Mycoplasma pneumoniae, Candida albicans, and Brucella, which were used for M-PCR of CTX and SHV genes, respectively, for determination of the specificity test.
Results
Results of Multiplex PCR Test on the Clinical Isolates
M-PCR test was done on extracted DNAs from the clinical isolates of E. coli. Among 100 isolates from the patients, 46 of them were positive for CTX gene and three of them were positive for the SHV gene. Based on these results, 49% of them were positive and none of them had these two genes together (Figures 1 and 2) . 
Determination of Limit of Detection and Specificity of PCR Test
The limit of detection of PCR test for CTX gene was 100 CFU and the SHV gene was 1000 CFU. In addition, by doing the PCR test on eight different strains of various bacteria for determining the specificity of test, no product was observed.
Antibiogram Test Result
This test was done on 100 isolates of E. coli based on CLSI standards and 17 isolates of them were considered as positive ones by disc diffusion test. By using the PCR method on these 17 positive isolates, 16 of them were found positive for CTX, and no positive SHV isolates were found ( Table 2 ).
Discussion
The beta-lactamase genes in bacteria, particularly ESBLs gene, are one of the effective factors in increasing the resistance to the related antibiotics such as cephalosporin. Organisms that carry these genes increase pathogenicity and mortality among the individuals, as well, the continuance of increasing in antibiotic resistance may endanger the society with serious problems (17, 18) . ESBLs are the beta-lactamase molecules of class A or D, which are able to hydrolyze the oxi-imunue-cephalosporin in an equal size or about 10% more than benzyl penicillin (9, 19) . Different types of these enzymes are increasing (20) . One of the most successful strategies for overcoming the resistance of beta-lactamase is the use of its inhibitors. This mechanism is based on the preventive activity by covalent joints 
Nalidixic acid 41
Chloramphenicol 2
Cefazolin 25
Cephalexin 19
Ceftriaxone 41
Tetracycline 58
Meropenem 0
Nitrofurantoin 3
Ceftazidime 23
Norfloxacin 1
Cotrimoxazole 58
Ceftazidime + clavulanic acid/cefotaxime + clavulanic acid 0 or links to the active site of beta-lactamase; class A. tazobactam, sulbactam, and clavulanic acid are the preventive materials of beta-lactamase inhibitors, which are commonly used in clinical studies (21) . In addition, enlargement of the active site, which increases the activity level against cephalosporin may increase the sensitivity of ESBLs to the inhibitors of beta-lactamase (22) . Comparison of the results of other studies shows that the frequency and prevalence of ESBLs is not the same in different parts of the world and, also their dispersion is not similar through the countries or even in different cities (23) . The long period of hospitalization, overuse of antibiotics (especially ceftazidime), hospitalization in the ICU ward, and the use of urinary catheters are the factors for producing ESBLs (24) . ESBLs-producing strains are usually the ones with multiple resistance (25) . Until 1999, most ESBLs isolated from the patients were TEM and SHV, however, in recent studies CTX-M beta-lactamase was isolated from patients and around the world, Enterobacteriaceae members containing blaCTX-M gene will be isolated (26) . It should be noted that there is extended-spectrum activity of the SHV -enzyme (27) . The difference of the actions may be caused by the replacement of the different amino acids in the active site of enzymes (28) (29) (30) . Since, phenotypic methods can only show the presence or absence of ESBL as well, the detection of this type of resistance in laboratory conditions was so difficult, and some of the resistant strains show their resistance under the In vivo conditions in spite of showing sensitive phenotype under the In vitro conditions. Therefore, for detecting a wide variety of beta-lactamase, extending the molecular methods such as PCR, which leads to a rapid and effective treatment and prevents the spread of resistant isolate of bacteria can be felt (31) . In the present study, among 100 isolates of E. coli, 49% of them consisted of ESBLs, which were obtained by Multiplex-PCR as well, 46% of E. coli isolates contained CTX genes and 3% of them consisted of SHV genes. (39) . Therefore, the rapid diagnosis of drug resistance contributing to community health can prevent further antibiotic resistance.
Conclusions
The production of ESBLs is significantly increasing. Therefore, in order to treat the infections with a factor producing beta-lactamase, antibiotics must be chosen with accuracy (40) . Rapid diagnostic techniques such as M-PCR have to be used to eradicate the spread and transmission of these ESBL-producing strains and the correct treatment of these strains in hospitals (16, 41) .
According to our results, the prevalence of blaSHV gene in samples collected from Milad Hospital is less than other studies mentioned in this article; in addition, the prevalence of blaCTX gene was almost similar to some other researches. 
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